Skip to main content

Table 1 Baseline characteristics of participants enrolled

From: The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial

Variable Turmeric group (n = 32) Placebo group
(n = 32)
P value
Age (years) 44.12 ± 8.35 38.56 ± 10.43 0.22
Sex(M/F) 19/13 19/13 1.000α
Smoking 3 (9.3%) 2 (6.25%) 1.000β
Height (cm) 167.84 ± 11.66 167.67 ± 9.15 0.948
Body weight (kg) 82.81 ± 14.37 85.16 ± 18.47 0.572
WC (cm) 104.72 ± 10.71 105.69 ± 15.06 0.768
HC(cm) 110.55 ± 9.10 110.61 ± 10.15 0.979
WHR 0.94 ± 0.04 0.95 ± 0.06 0.722
BMI (kg/m2) 29.51 ± 4.96 30.15 ± 5.10 0.613
SBP (mmHg) 129.00 ± 16.96 124.97 ± 16.97 0.346
DBP (mmHg) 81.84 ± 8.38 81.18 ± 9.38 0.769
Energy (kcal/day) 2199.0 ± 625.2 2059.9 ± 620.2 0.375
Protein (g/day) 91.52 ± 40.87 76.13 ± 24.17 0.072
Fat (g/day) 70.38 ± 32.64 62.46 ± 29.17 0.310
Carbohydrate (g/day) 312.16 ± 11.77 305.52 ± 10.41 0.812
  1. Values presented as mean ± SD
  2. M male, F female, SBP systolic blood pressure, DBP diastolic blood pressure, WC waist circumference, HC hip circumference, WHR waist-to-hip ratio, BMI body mass index
  3. 1Analyzed by Independent t-test
  4. 2Values are presented as mean ± SD
  5. αAnalyzed by Pearson χ2
  6. βAnalyzed by Fisher’s exact-test